CDH1 and inflammatory breast carcinoma: Taken together, our findings demonstrate that DCN acts as a tumor- and metastasis suppressor in IBC by accelerating the autophagic degradation of E-cadherin and suppressing activation of EGFR–ERK signaling (Fig. 6e).